Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
XG-102 administered to healthy male volunteers as a single intravenous infusion: a randomized, double-blind, placebo-controlled, dose-escalating study.

Pharmacology research & perspectives

Deloche C, Lopez-Lazaro L, Mouz S, Perino J, Abadie C, Combette JM.
PMID: 25505576
Pharmacol Res Perspect. 2014 Feb;2(1):e00020. doi: 10.1002/prp2.20. Epub 2014 Jan 26.

The aim of the study is to evaluate the safety, tolerability and pharmacokinetics (PK) of the JNK inhibitor XG-102 in a randomized, double blind, placebo controlled, sequential ascending dose parallel group Phase 1 Study. Three groups of male subjects...

Cite
Deloche C, Lopez-Lazaro L, Mouz S, et al. XG-102 administered to healthy male volunteers as a single intravenous infusion: a randomized, double-blind, placebo-controlled, dose-escalating study. Pharmacol Res Perspect. 2014;2(1):e00020doi: 10.1002/prp2.20.
Deloche, C., Lopez-Lazaro, L., Mouz, S., Perino, J., Abadie, C., & Combette, J. M. (2014). XG-102 administered to healthy male volunteers as a single intravenous infusion: a randomized, double-blind, placebo-controlled, dose-escalating study. Pharmacology research & perspectives, 2(1), e00020. https://doi.org/10.1002/prp2.20
Deloche, Catherine, et al. "XG-102 administered to healthy male volunteers as a single intravenous infusion: a randomized, double-blind, placebo-controlled, dose-escalating study." Pharmacology research & perspectives vol. 2,1 (2014): e00020. doi: https://doi.org/10.1002/prp2.20
Deloche C, Lopez-Lazaro L, Mouz S, Perino J, Abadie C, Combette JM. XG-102 administered to healthy male volunteers as a single intravenous infusion: a randomized, double-blind, placebo-controlled, dose-escalating study. Pharmacol Res Perspect. 2014 Feb;2(1):e00020. doi: 10.1002/prp2.20. Epub 2014 Jan 26. PMID: 25505576; PMCID: PMC4186400.
Copy Download .nbib Format: NLM
Exploring the Effect of Cooperation in Reducing Implicit Racial Bias and Its Relationship With Dispositional Empathy and Political Attitudes.

Frontiers in psychology

Patané I, Lelgouarch A, Banakou D, Verdelet G, Desoche C, Koun E, Salemme R, Slater M, Farnè A.
PMID: 33192759
Front Psychol. 2020 Oct 28;11:510787. doi: 10.3389/fpsyg.2020.510787. eCollection 2020.

Previous research using immersive virtual reality (VR) has shown that after a short period of embodiment by White people in a Black virtual body, their implicit racial bias against Black people diminishes. Here we tested the effects of some...

Cite
Patané I, Lelgouarch A, Banakou D, et al. Exploring the Effect of Cooperation in Reducing Implicit Racial Bias and Its Relationship With Dispositional Empathy and Political Attitudes. Front Psychol. 2020;11:510787doi: 10.3389/fpsyg.2020.510787.
Patané, I., Lelgouarch, A., Banakou, D., Verdelet, G., Desoche, C., Koun, E., Salemme, R., Slater, M., & Farnè, A. (2020). Exploring the Effect of Cooperation in Reducing Implicit Racial Bias and Its Relationship With Dispositional Empathy and Political Attitudes. Frontiers in psychology, 11510787. https://doi.org/10.3389/fpsyg.2020.510787
Patané, Ivan, et al. "Exploring the Effect of Cooperation in Reducing Implicit Racial Bias and Its Relationship With Dispositional Empathy and Political Attitudes." Frontiers in psychology vol. 11 (2020): 510787. doi: https://doi.org/10.3389/fpsyg.2020.510787
Patané I, Lelgouarch A, Banakou D, Verdelet G, Desoche C, Koun E, Salemme R, Slater M, Farnè A. Exploring the Effect of Cooperation in Reducing Implicit Racial Bias and Its Relationship With Dispositional Empathy and Political Attitudes. Front Psychol. 2020 Oct 28;11:510787. doi: 10.3389/fpsyg.2020.510787. eCollection 2020. PMID: 33192759; PMCID: PMC7655932.
Copy Download .nbib Format: NLM
Correction to: Forecasting Content and Stage in a Nursing Home Information Technology Maturity Instrument Using a Delphi Method.

Journal of medical systems

Alexander GL, Deroche C, Powell K, Mosa ASM, Popejoy L, Koopman R.
PMID: 32103351
J Med Syst. 2020 Feb 26;44(4):74. doi: 10.1007/s10916-020-1544-6.

The original article unfortunately contained a mistake.

Cite
Alexander GL, Deroche C, Powell K, et al. Correction to: Forecasting Content and Stage in a Nursing Home Information Technology Maturity Instrument Using a Delphi Method. J Med Syst. 2020;44(4):74doi: 10.1007/s10916-020-1544-6.
Alexander, G. L., Deroche, C., Powell, K., Mosa, A. S. M., Popejoy, L., & Koopman, R. (2020). Correction to: Forecasting Content and Stage in a Nursing Home Information Technology Maturity Instrument Using a Delphi Method. Journal of medical systems, 44(4), 74. https://doi.org/10.1007/s10916-020-1544-6
Alexander, Gregory L, et al. "Correction to: Forecasting Content and Stage in a Nursing Home Information Technology Maturity Instrument Using a Delphi Method." Journal of medical systems vol. 44,4 (2020): 74. doi: https://doi.org/10.1007/s10916-020-1544-6
Alexander GL, Deroche C, Powell K, Mosa ASM, Popejoy L, Koopman R. Correction to: Forecasting Content and Stage in a Nursing Home Information Technology Maturity Instrument Using a Delphi Method. J Med Syst. 2020 Feb 26;44(4):74. doi: 10.1007/s10916-020-1544-6. PMID: 32103351; PMCID: PMC7265649.
Copy Download .nbib Format: NLM
Evaluation of the Revogene® GBS DS assay performance for the intrapartum screening of group B streptococcus in comparison with intrapartum culture.

Diagnostic microbiology and infectious disease

Meex C, Devey A, Defêche J, Bontems S, Descy J, Hayette MP, Sacheli R, Melin P.
PMID: 34974352
Diagn Microbiol Infect Dis. 2021 Dec 09;102(3):115616. doi: 10.1016/j.diagmicrobio.2021.115616. Epub 2021 Dec 09.

Prevention of perinatal Group B Streptococcus (GBS) transmission is crucial in our effort to prevent Early-onset GBS disease. Here, we established the performance of the Revogene GBS DS assay for the detection of group B streptococcus on intrapartum vaginal...

Cite
Meex C, Devey A, Defêche J, et al. Evaluation of the Revogene® GBS DS assay performance for the intrapartum screening of group B streptococcus in comparison with intrapartum culture. Diagn Microbiol Infect Dis. 2021;102(3):115616doi: 10.1016/j.diagmicrobio.2021.115616.
Meex, C., Devey, A., Defêche, J., Bontems, S., Descy, J., Hayette, M. P., Sacheli, R., & Melin, P. (2021). Evaluation of the Revogene® GBS DS assay performance for the intrapartum screening of group B streptococcus in comparison with intrapartum culture. Diagnostic microbiology and infectious disease, 102(3), 115616. https://doi.org/10.1016/j.diagmicrobio.2021.115616
Meex, Cécile, et al. "Evaluation of the Revogene® GBS DS assay performance for the intrapartum screening of group B streptococcus in comparison with intrapartum culture." Diagnostic microbiology and infectious disease vol. 102,3 (2021): 115616. doi: https://doi.org/10.1016/j.diagmicrobio.2021.115616
Meex C, Devey A, Defêche J, Bontems S, Descy J, Hayette MP, Sacheli R, Melin P. Evaluation of the Revogene® GBS DS assay performance for the intrapartum screening of group B streptococcus in comparison with intrapartum culture. Diagn Microbiol Infect Dis. 2021 Dec 09;102(3):115616. doi: 10.1016/j.diagmicrobio.2021.115616. Epub 2021 Dec 09. PMID: 34974352.
Copy Download .nbib Format: NLM
Insomnia treatment effects among young adult drinkers: Secondary outcomes of a randomized pilot trial.

Alcoholism, clinical and experimental research

Miller MB, Freeman L, Park CJ, Hall NA, Deroche C, Sahota PK, McCrae CS.
PMID: 33745147
Alcohol Clin Exp Res. 2021 May;45(5):1136-1148. doi: 10.1111/acer.14603. Epub 2021 Apr 05.

BACKGROUND: Cognitive behavioral therapy for insomnia (CBT-I) has moderate-to-large effects on insomnia among young adult drinkers, with preliminary data indicating that improvements in insomnia may have downstream effects on alcohol-related consequences. However, the mechanism(s) by which insomnia treatment may...

Cite
Miller MB, Freeman L, Park CJ, et al. Insomnia treatment effects among young adult drinkers: Secondary outcomes of a randomized pilot trial. Alcohol Clin Exp Res. 2021;45(5):1136-1148doi: 10.1111/acer.14603.
Miller, M. B., Freeman, L., Park, C. J., Hall, N. A., Deroche, C., Sahota, P. K., & McCrae, C. S. (2021). Insomnia treatment effects among young adult drinkers: Secondary outcomes of a randomized pilot trial. Alcoholism, clinical and experimental research, 45(5), 1136-1148. https://doi.org/10.1111/acer.14603
Miller, Mary Beth, et al. "Insomnia treatment effects among young adult drinkers: Secondary outcomes of a randomized pilot trial." Alcoholism, clinical and experimental research vol. 45,5 (2021): 1136-1148. doi: https://doi.org/10.1111/acer.14603
Miller MB, Freeman L, Park CJ, Hall NA, Deroche C, Sahota PK, McCrae CS. Insomnia treatment effects among young adult drinkers: Secondary outcomes of a randomized pilot trial. Alcohol Clin Exp Res. 2021 May;45(5):1136-1148. doi: 10.1111/acer.14603. Epub 2021 Apr 05. PMID: 33745147; PMCID: PMC8131236.
Copy Download .nbib Format: NLM
A National Assessment of Access to Technology Among Nursing Home Residents: A Secondary Analysis.

JMIR aging

Powell KR, Alexander GL, Madsen R, Deroche C.
PMID: 31518285
JMIR Aging. 2019 Mar 05;2(1):e11449. doi: 10.2196/11449.

BACKGROUND: According to the National Center for Health Statistics, there are over 1.7 million nursing home residents in the United States. Nursing home residents and their family members have unique needs and stand to benefit from using technology empowering...

Cite
Powell KR, Alexander GL, Madsen R, et al. A National Assessment of Access to Technology Among Nursing Home Residents: A Secondary Analysis. JMIR Aging. 2019;2(1):e11449doi: 10.2196/11449.
Powell, K. R., Alexander, G. L., Madsen, R., & Deroche, C. (2019). A National Assessment of Access to Technology Among Nursing Home Residents: A Secondary Analysis. JMIR aging, 2(1), e11449. https://doi.org/10.2196/11449
Powell, Kimberly Ryan, et al. "A National Assessment of Access to Technology Among Nursing Home Residents: A Secondary Analysis." JMIR aging vol. 2,1 (2019): e11449. doi: https://doi.org/10.2196/11449
Powell KR, Alexander GL, Madsen R, Deroche C. A National Assessment of Access to Technology Among Nursing Home Residents: A Secondary Analysis. JMIR Aging. 2019 Mar 05;2(1):e11449. doi: 10.2196/11449. PMID: 31518285; PMCID: PMC6714997.
Copy Download .nbib Format: NLM
In-Depth Longitudinal Comparison of Clinical Specimens to Detect SARS-CoV-2.

Pathogens (Basel, Switzerland)

Defêche J, Azarzar S, Mesdagh A, Dellot P, Tytgat A, Bureau F, Gillet L, Belhadj Y, Bontems S, Hayette MP, Schils R, Rahmouni S, Ernst M, Moutschen M, Darcis G.
PMID: 34832518
Pathogens. 2021 Oct 21;10(11). doi: 10.3390/pathogens10111362.

The testing and isolation of patients with coronavirus disease 2019 (COVID-19) are indispensable tools to control the ongoing COVID-19 pandemic. PCR tests are considered the "gold standard" of COVID-19 testing and mostly involve testing nasopharyngeal swab specimens. Our study...

Cite
Defêche J, Azarzar S, Mesdagh A, et al. In-Depth Longitudinal Comparison of Clinical Specimens to Detect SARS-CoV-2. Pathogens. 2021;10(11)doi: 10.3390/pathogens10111362.
Defêche, J., Azarzar, S., Mesdagh, A., Dellot, P., Tytgat, A., Bureau, F., Gillet, L., Belhadj, Y., Bontems, S., Hayette, M. P., Schils, R., Rahmouni, S., Ernst, M., Moutschen, M., & Darcis, G. (2021). In-Depth Longitudinal Comparison of Clinical Specimens to Detect SARS-CoV-2. Pathogens (Basel, Switzerland), 10(11), . https://doi.org/10.3390/pathogens10111362
Defêche, Justine, et al. "In-Depth Longitudinal Comparison of Clinical Specimens to Detect SARS-CoV-2." Pathogens (Basel, Switzerland) vol. 10,11 (2021). doi: https://doi.org/10.3390/pathogens10111362
Defêche J, Azarzar S, Mesdagh A, Dellot P, Tytgat A, Bureau F, Gillet L, Belhadj Y, Bontems S, Hayette MP, Schils R, Rahmouni S, Ernst M, Moutschen M, Darcis G. In-Depth Longitudinal Comparison of Clinical Specimens to Detect SARS-CoV-2. Pathogens. 2021 Oct 21;10(11). doi: 10.3390/pathogens10111362. PMID: 34832518; PMCID: PMC8622859.
Copy Download .nbib Format: NLM
Patient Perspectives on Short-Course Pharmacotherapy: Barriers and Facilitators to Medication Adherence.

Journal of patient experience

Sherwin LB, Ross D, Matteson-Kome M, Bechtold M, Deroche C, Wakefield B.
PMID: 33294608
J Patient Exp. 2020 Oct;7(5):726-733. doi: 10.1177/2374373519882230. Epub 2019 Oct 23.

BACKGROUND: Medication nonadherence is a public health issue that contributes to poor health outcomes and health-care costs. Factors influencing long-term medication adherence are known; however, little is known about short-course medication adherence.OBJECTIVE: This study examined patient perspectives on adherence...

Cite
Sherwin LB, Ross D, Matteson-Kome M, et al. Patient Perspectives on Short-Course Pharmacotherapy: Barriers and Facilitators to Medication Adherence. J Patient Exp. 2019;7(5):726-733doi: 10.1177/2374373519882230.
Sherwin, L. B., Ross, D., Matteson-Kome, M., Bechtold, M., Deroche, C., & Wakefield, B. (2020). Patient Perspectives on Short-Course Pharmacotherapy: Barriers and Facilitators to Medication Adherence. Journal of patient experience, 7(5), 726-733. https://doi.org/10.1177/2374373519882230
Sherwin, LeeAnne B, et al. "Patient Perspectives on Short-Course Pharmacotherapy: Barriers and Facilitators to Medication Adherence." Journal of patient experience vol. 7,5 (2020): 726-733. doi: https://doi.org/10.1177/2374373519882230
Sherwin LB, Ross D, Matteson-Kome M, Bechtold M, Deroche C, Wakefield B. Patient Perspectives on Short-Course Pharmacotherapy: Barriers and Facilitators to Medication Adherence. J Patient Exp. 2020 Oct;7(5):726-733. doi: 10.1177/2374373519882230. Epub 2019 Oct 23. PMID: 33294608; PMCID: PMC7705821.
Copy Download .nbib Format: NLM
Showing 1 to 8 of 8 entries